7487 Results

People

  1. Brennan
    Brennan
  2. Danishefsky
    Danishefsky
  3. Larson
    Larson
  4. Scheinberg
    Scheinberg
  5. Fuks
    Fuks
  6. Rosen
    Rosen
  7. Hricak
    Hricak
  8. Pasternak
    Pasternak
  9. Sadelain
    Sadelain
  10. Scardino
    Scardino

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)
  7. Radiology, Department of (1814)
  8. Hematologic Malignancies Research (1617)
  9. Hematologic Malignancies, Division of (1517)
  10. Center for Molecular Imaging and Biotechnology (1341)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An HSP90 inhibitor, PU-H71, antagonizes stroma-induced pro-survival effects in CLL through its inhibition of multi-component B-cell receptor signaling pathway
    Meeting Abstract

    Guo, A. L.; Lu, P.; Zhen, C.; Chiosis, G.; Wang, Y. L.
    Blood (2015)

    Fulltext@MSK | Save
  • Functional proteomics of regulatory and epigenetic signaling in normal and malignant hematopoiesis
    Meeting Abstract

    Cifani, P.; Shakiba, M.; Brown, F.; Dhabaria, A.; Bauer, D. E.; Kentsis, A.
    Blood (2015)

    Fulltext@MSK | Save
  • Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A therapeutic TCR mimic monoclonal antibody for intracellular PRAME protein in leukemias
    Meeting Abstract

    Chang, A.; Dao, T.; Scott, A.; Dubrovsky, L.; Liu, C.; Scheinberg, D. A.
    Blood (2015)

    Fulltext@MSK | Save
  • From T-cell engineering to CAR therapy: Progress and prospects
    Meeting Abstract

    Sadelain, M.
    Blood (2015)

    Fulltext@MSK | Save
  • Targeting the Hsp90 oncoproteome in Burkitt lymphoma
    Meeting Abstract

    Roth, L. G.; van Besien, H.; Rodina, A.; Taldone, T.; Erdjument-Bromage, H.; Barth, M. J.; Chiosis, G.; Cesarman, E.
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • IKZF2, a novel target of MSI2 RNA-binding protein plays an oncogenic role in myeloid leukemia
    Meeting Abstract

    Park, S. M.; Thornton, A.; Vu, L. P.; Chhangawala, S.; Minuesa, G.; Barlowe, T.; Taggart, J.; Tivnan, P.; Kim, T.; Shevach, E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Diverse mechanisms of vemurafenib resistance in BRAF-mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Durham, B.; Chung, Y. R.; Scott, S.; Getta, B.; Kim, E.; Saven, A.; Stone, R. M.; Rai, K. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • MSI2 is required for maintaining the activated myelodysplastic syndrome stem cell
    Meeting Abstract

    Ho, T. C.; Taggart, J.; Amin, E.; Xu, H. M.; Barlowe, T.; Perez, A. R.; Tivnan, P.; Okabe, R.; Lengner, C.; Verma, A.; more...
    Blood (2015)

    Fulltext@MSK | Save